Literature DB >> 20871098

Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy.

Matthew E Gegg1, J Mark Cooper, Kai-Yin Chau, Manuel Rojo, Anthony H V Schapira, Jan-Willem Taanman.   

Abstract

Mitochondrial dysfunction and perturbed degradation of proteins have been implicated in Parkinson's disease (PD) pathogenesis. Mutations in the Parkin and PINK1 genes are a cause of familial PD. PINK1 is a putative kinase associated with mitochondria, and loss of PINK1 expression leads to mitochondrial dysfunction, which increases with time. Parkin is suggested to be downstream of PINK1 and also mediates the removal of damaged mitochondria by macroautophagy (mitophagy). We investigated whether mitochondrial dysfunction in dopaminergic SH-SY5Y cells following decreased PINK1 expression by RNAi may in part be due to the inhibition of mitophagy. Reduced flux through the macroautophagy pathway was found to be coincident with the inhibition of ATP synthesis following 12 days of PINK1 silencing. Overexpression of parkin in these cells restored both autophagic flux and ATP synthesis. Overexpression and RNAi studies also indicated that PINK1 and parkin were required for mitophagy following CCCP-induced mitochondrial damage. The ubiquitination of several mitochondrial proteins, including mitofusin 1 and mitofusin 2, were detected within 3 h of CCCP treatment. These post-translational modifications were reduced following the silencing of parkin or PINK1. The ubiquitination of mitochondrial proteins appears to identify mitochondria for degradation and facilitate mitophagy. PINK1 and parkin are thus required for the removal of damaged mitochondria in dopaminergic cells, and inhibition of this pathway may lead to the accumulation of defective mitochondria which may contribute to PD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20871098      PMCID: PMC3583518          DOI: 10.1093/hmg/ddq419

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  61 in total

1.  Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin.

Authors:  Nicole Exner; Bettina Treske; Dominik Paquet; Kira Holmström; Carola Schiesling; Suzana Gispert; Iria Carballo-Carbajal; Daniela Berg; Hans-Hermann Hoepken; Thomas Gasser; Rejko Krüger; Konstanze F Winklhofer; Frank Vogel; Andreas S Reichert; Georg Auburger; Philipp J Kahle; Bettina Schmid; Christian Haass
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

2.  PINK1-dependent recruitment of Parkin to mitochondria in mitophagy.

Authors:  Cristofol Vives-Bauza; Chun Zhou; Yong Huang; Mei Cui; Rosa L A de Vries; Jiho Kim; Jessica May; Maja Aleksandra Tocilescu; Wencheng Liu; Han Seok Ko; Jordi Magrané; Darren J Moore; Valina L Dawson; Regis Grailhe; Ted M Dawson; Chenjian Li; Kim Tieu; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

3.  The mitochondrial fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathway.

Authors:  Angela C Poole; Ruth E Thomas; Selina Yu; Evelyn S Vincow; Leo Pallanck
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

4.  Metabolic dysfunction and depletion of mitochondria in hearts of septic rats.

Authors:  J A Watts; J A Kline; L R Thornton; R M Grattan; S S Brar
Journal:  J Mol Cell Cardiol       Date:  2004-01       Impact factor: 5.000

5.  Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice.

Authors:  Tohru Kitada; Antonio Pisani; Douglas R Porter; Hiroo Yamaguchi; Anne Tscherter; Giuseppina Martella; Paola Bonsi; Chen Zhang; Emmanuel N Pothos; Jie Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

6.  Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology.

Authors:  A Grünewald; M E Gegg; J-W Taanman; R H King; N Kock; C Klein; A H V Schapira
Journal:  Exp Neurol       Date:  2009-06-03       Impact factor: 5.330

Review 7.  The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease.

Authors:  Tianhong Pan; Seiji Kondo; Weidong Le; Joseph Jankovic
Journal:  Brain       Date:  2008-01-10       Impact factor: 13.501

8.  Hereditary early-onset Parkinson's disease caused by mutations in PINK1.

Authors:  Enza Maria Valente; Patrick M Abou-Sleiman; Viviana Caputo; Miratul M K Muqit; Kirsten Harvey; Suzana Gispert; Zeeshan Ali; Domenico Del Turco; Anna Rita Bentivoglio; Daniel G Healy; Alberto Albanese; Robert Nussbaum; Rafael González-Maldonado; Thomas Deller; Sergio Salvi; Pietro Cortelli; William P Gilks; David S Latchman; Robert J Harvey; Bruno Dallapiccola; Georg Auburger; Nicholas W Wood
Journal:  Science       Date:  2004-04-15       Impact factor: 47.728

9.  Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells.

Authors:  Matthew E Gegg; J Mark Cooper; Anthony H V Schapira; Jan-Willem Taanman
Journal:  PLoS One       Date:  2009-03-09       Impact factor: 3.240

10.  PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons.

Authors:  Alison Wood-Kaczmar; Sonia Gandhi; Zhi Yao; Andrey Y Abramov; Andrey S Y Abramov; Erik A Miljan; Gregory Keen; Lee Stanyer; Iain Hargreaves; Kristina Klupsch; Emma Deas; Julian Downward; Louise Mansfield; Parmjit Jat; Joanne Taylor; Simon Heales; Michael R Duchen; David Latchman; Sarah J Tabrizi; Nicholas W Wood
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

View more
  395 in total

Review 1.  The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson's disease.

Authors:  Victor S Van Laar; Sarah B Berman
Journal:  Neurobiol Dis       Date:  2012-06-02       Impact factor: 5.996

Review 2.  Regulation of autophagy by protein post-translational modification.

Authors:  Willayat Yousuf Wani; Michaël Boyer-Guittaut; Matthew Dodson; John Chatham; Victor Darley-Usmar; Jianhua Zhang
Journal:  Lab Invest       Date:  2014-11-03       Impact factor: 5.662

Review 3.  Recent advances in the genetics of Parkinson's disease.

Authors:  Ian Martin; Valina L Dawson; Ted M Dawson
Journal:  Annu Rev Genomics Hum Genet       Date:  2011       Impact factor: 8.929

4.  The Upshot of LRRK2 Inhibition to Parkinson's Disease Paradigm.

Authors:  A R Esteves; M G-Fernandes; D Santos; C Januário; S M Cardoso
Journal:  Mol Neurobiol       Date:  2014-11-15       Impact factor: 5.590

5.  Mitofusin function is dependent on the distinct tissue and organ specific roles of mitochondria.

Authors:  Michael N Sack
Journal:  J Mol Cell Cardiol       Date:  2011-09-12       Impact factor: 5.000

Review 6.  Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorder.

Authors:  Yuzuru Imai; Bingwei Lu
Journal:  Curr Opin Neurobiol       Date:  2011-11-01       Impact factor: 6.627

Review 7.  Mechanisms of mitochondria and autophagy crosstalk.

Authors:  Angelika S Rambold; Jennifer Lippincott-Schwartz
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

Review 8.  Mitochondrial morphology-emerging role in bioenergetics.

Authors:  Chad A Galloway; Hakjoo Lee; Yisang Yoon
Journal:  Free Radic Biol Med       Date:  2012-09-29       Impact factor: 7.376

Review 9.  Integration of cellular bioenergetics with mitochondrial quality control and autophagy.

Authors:  Bradford G Hill; Gloria A Benavides; Jack R Lancaster; Scott Ballinger; Lou Dell'Italia; Zhang Jianhua; Victor M Darley-Usmar
Journal:  Biol Chem       Date:  2012-12       Impact factor: 3.915

Review 10.  Current perspective of mitochondrial biology in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Bobby Thomas
Journal:  Neurochem Int       Date:  2018-03-14       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.